10-Q: Aemetis Q3 2025: Revenue Plunges, Going Concern Doubt Raised

Aemetis, Inc. reported a significant revenue decline and increased net loss for Q3 2025, leading management to express substantial doubt about its ability to continue as a going concern.

Summary

• Total revenues for Q3 2025 decreased by 27.3% to $59.19 million from $81.44 million in Q3 2024.
• The company reported a gross loss of $58 thousand in Q3 2025, a significant decline from a gross profit of $3.88 million in Q3 2024.
• Net loss for Q3 2025 increased to $23.75 million from $17.94 million in Q3 2024.
• Year-to-date (nine months ended September 30, 2025) revenues decreased by 30.1% to $154.32 million from $220.64 million in the prior year period.
• Year-to-date gross loss was $8.49 million, compared to a gross profit of $1.46 million in the same period last year.
• Net cash used in operating activities improved significantly, decreasing to $2.51 million for the nine months ended September 30, 2025, from $20.35 million in the prior year period.
• Current portion of long-term debt surged to $266.11 million as of September 30, 2025, from $63.75 million at December 31, 2024.
• Management expressed substantial doubt about the company's ability to continue as a going concern over the next twelve months due to significant debt and expected near-term cash flow shortfalls.

Sentiment

Score: 2

Explanation: The company reported substantial revenue declines and increased net losses across key segments, leading to a gross loss. The reclassification of a significant portion of long-term debt to current liabilities highlights immediate financial pressure. Management's explicit statement of "substantial doubt about our ability to continue as a going concern" is a severe negative indicator, despite some positive developments in tax credits and project advancements.

Positives

• Net cash used in operating activities for the nine months ended September 30, 2025, significantly decreased to $2.51 million from $20.35 million in the prior year.
• Cash and cash equivalents increased to $5.58 million as of September 30, 2025, from $0.90 million at December 31, 2024.
• Provisional LCFS pathways were approved for seven dairy locations in Q2 2025, expected to increase LCFS credit revenue from those dairies by approximately 160% starting Q4 2025.
• CARB's recently approved amendments to the LCFS regulation, effective July 1, 2025, are expected to reduce oversupply of LCFS credits and lead to higher credit prices.
• The Keyes Plant started earning Section 45Z tax credits effective January 1, 2025, with recent federal legislation expected to increase future income from these credits and extend their term to five years.
• RNG production also started earning Section 45Z production tax credits effective January 1, 2025, with recent federal legislation expected to increase future income from these credits and extend their term to five years.
• The India Biodiesel segment has been self-sustaining from a cash and liquidity perspective for several years and is expected to continue this trend.
• The Mechanical Vapor Recompression (MVR) system at the Keyes Plant, expected to be operational in H1 2026, will reduce natural gas consumption by about 80% and lower ethanol carbon intensity, reducing fuel costs and increasing LCFS and Section 45Z tax credit income.

Negatives

• Total revenues for Q3 2025 decreased by 27.3% compared to Q3 2024, and year-to-date revenues decreased by 30.1%.
• The company reported a gross loss of $58 thousand in Q3 2025, a significant decline from a gross profit of $3.88 million in Q3 2024.
• Net loss for Q3 2025 increased to $23.75 million from $17.94 million in Q3 2024, and year-to-date net loss was $71.67 million compared to $71.34 million in the prior year.
• The India Biodiesel segment experienced a 55.1% decrease in Q3 2025 revenues and a 67.6% decrease in year-to-date revenues, primarily due to delays in receiving tender contracts from OMCs and a shift to fixed-price contracts.
• California Ethanol segment revenues decreased by 9.4% in Q3 2025 due to scaled-back production, lower ethanol and WDG sales volumes, and a 10% decrease in WDG average price.
• California Dairy Renewable Natural Gas segment gross profit decreased by 31.5% in Q3 2025 due to increased costs of goods sold for more operating digesters.
• Current liabilities significantly increased to $343.37 million as of September 30, 2025, from $143.97 million at December 31, 2024, largely due to the reclassification of long-term debt to current.
• Accumulated deficit worsened to $634.61 million as of September 30, 2025, from $562.94 million at December 31, 2024.
• Selling, general and administrative expenses as a percentage of revenue increased to 14% in Q3 2025 from 10% in Q3 2024, and to 17% year-to-date from 13% in the prior year.
• Interest expense and debt-related fees increased in Q3 2025 and year-to-date due to higher variable interest rates and increased debt balances.

Risks

• Substantial doubt about the ability to continue as a going concern over the next twelve months due to significant debt and expected near-term cash flow shortfalls.
• Reliance on the senior secured lender (Third Eye Capital) for extensions to debt maturity dates and continued cooperation.
• Risk of not having sufficient cash to pay debt if the senior lender does not extend debt or if alternative financing is not obtained.
• Volatility in market prices for input costs (corn, waste fats and oils, natural gas) and product revenues (ethanol, WDG, DCO, CDS, biodiesel, glycerin, LCFS credits, D3 RINs).
• Potential for periods where the spread between ethanol prices and corn/energy costs narrows, or the value of environmental attributes/tax credits is reduced, requiring additional working capital.
• Material weaknesses in internal controls related to information technology general controls and information technology systems, as well as documentation, identified in the 2024 Annual Report on Form 10-K.
• Legal proceedings: Litigation initiated by a broker in April 2025 to collect $2.3 million (plus interest and fees) under a settlement agreement.
• Third Eye Capital Keyes Notes contain various covenants, including debt to plant value ratio, minimum production requirements, and restrictions on capital expenditures, with a risk of acceleration of maturity in the event of a default.
• Loans under the Fuels Revolving Line are now due on demand.

Future Outlook

The company plans to optimize California Ethanol operations, reduce natural gas use with an MVR system by H1 2026, and monetize new Section 45Z tax credits, which are expected to increase due to recent federal legislation. In California Dairy RNG, the company will continue building new digesters, with the next set expected to produce biogas in Q2 2026, and anticipates increased LCFS credit revenue from approved provisional pathways and new CARB regulations. The India Biodiesel segment aims to continue sales to OMCs, expand operations, and plans for a potential public stock offering of its India subsidiary. Overall, the company expects to continue raising cash through equity sales and seeking additional debt and project-specific funding, but acknowledges substantial doubt about its ability to continue as a going concern.

Management Comments

• We plan to continue to operate the Keyes Plant and to optimize operating parameters based on market conditions.
• We are constructing a Mechanical Vapor Recompression ("MVR") system that will reduce the Keyes Plant's natural gas consumption by about 80% and lower the carbon intensity of the ethanol produced at the Plant.
• We plan to continue to build new dairy digesters that increase cash flow as allowed by capital availability.
• We are seeking debt from a variety of sources to facilitate additional digester construction.
• We plan to continue to operate the Kakinada Plant to produce biodiesel and glycerin and to sell the biodiesel to government-owned Oil Marketing Companies ("OMCs").
• We have hired a new executive team in India to help develop plans for additional growth of our India business and to execute on a potential public stock offering of our India subsidiary.
• Our India business has been self-sustaining from a cash and liquidity perspective for several years, and we expect this to continue.
• We have been raising cash for operations by selling equity through our at-the-market stock registration, and we expect to continue to do so.
• We also plan to seek additional funding for existing and new business opportunities through a combination of working with our senior lender, restructuring or refinancing existing loan agreements, entering into additional debt agreements for specific projects, obtaining project specific equity and debt for development projects, and obtaining additional debt from the current EB-5 Phase II offering.
• Notwithstanding our plans to improve liquidity and these favorable recent events, the extent of our debt and reliance on our senior secured lender, along with expected near-term shortfalls in cash flow from operations, require us to state that there is substantial doubt about our ability to continue as a going concern over the next twelve months.

Industry Context

Aemetis operates within the renewable fuels and bioeconomy sectors, which are heavily influenced by governmental carbon reduction incentives like California's LCFS, federal RFS D3 RINs, and Section 45Z production tax credits. The company's focus on lower-carbon intensity fuels, such as renewable natural gas from dairy waste and sustainable aviation fuel, aligns with global trends towards decarbonization and circular bioeconomies. However, the volatility in feedstock and product prices, as well as the reliance on government tenders (e.g., India OMCs), highlights the regulatory and market-dependent nature of this industry. The company's significant debt and going concern warning suggest challenges in scaling up capital-intensive renewable energy projects amidst fluctuating market conditions and financing constraints.

Management Changes

Corporate Governance

Legal Proceedings

• Litigation initiated by a broker against Aemetis, Inc. in April 2025 to collect $2.3 million (plus interest and fees) under a settlement agreement.

Related Party Transactions

• The company owes Eric McAfee (Chairman and CEO) and McAfee Capital LLC (owned by Mr. McAfee) $1.3 million as of September 30, 2025, for employment agreements, bonus awards, expense reimbursements, and guarantee fees related to guarantees of the company's indebtedness to Third Eye Capital.

Stakeholder Impact

• Shareholders: Significant dilution from ongoing equity sales, increased accumulated deficit, and substantial doubt about going concern status could negatively impact share value.
• Creditors (Third Eye Capital): High reliance on their continued cooperation for debt extensions and refinancing, with a substantial portion of debt now current, indicating increased risk.
• Employees: Potential uncertainty due to the going concern warning, though the company is pursuing growth strategies and has hired a new executive team in India.
• Customers: Delays in tender contracts for India Biodiesel indicate potential supply chain or contractual issues impacting customer relationships in that segment.
• Suppliers (J.D. Heiskell, dairy operators, Gemini Edibles): Continued relationships are crucial for operations, with J.D. Heiskell being a key supplier and customer for California Ethanol.

Next Steps

• Refinance debt with the senior lender or receive its continued cooperation to meet obligations in the next twelve months.
• Continue to operate the Keyes Plant and optimize operating parameters based on market conditions.
• Complete construction of the Mechanical Vapor Recompression (MVR) system at the Keyes Plant, expected to be operational in H1 2026.
• Monetize Section 45Z tax credits earned from ethanol and RNG production.
• Evaluate other opportunities to improve the Keyes Plant's financial performance by adopting new technologies or process changes.
• Continue to build new dairy digesters, with the next set expected to begin producing biogas in Q2 2026.
• Seek debt from a variety of sources to facilitate additional digester construction.
• Obtain more provisional LCFS pathways for the five operating digesters currently generating LCFS credits under temporary pathways.
• Continue to operate the Kakinada Plant to produce biodiesel and glycerin and sell to OMCs.
• Develop plans for additional growth of the India business and execute on a potential public stock offering of the India subsidiary.
• Continue selling equity through the at-the-market stock registration.
• Seek additional funding for existing and new business opportunities through various debt and equity arrangements.
• Execute remediation plans to address material weaknesses in internal controls related to information technology general controls and systems, as well as documentation.
• Redeem all outstanding Series A Preferred Units by December 31, 2025, or enter into a credit agreement with Protair-X and Third Eye Capital effective January 1, 2026.

Key Dates

Recommendation

The filing presents a highly concerning financial picture. Aemetis reported significant revenue declines, increased net losses, and a shift from gross profit to gross loss. The reclassification of a substantial portion of long-term debt to current liabilities indicates severe near-term liquidity challenges. Most critically, management explicitly stated "substantial doubt about our ability to continue as a going concern over the next twelve months." This, coupled with ongoing reliance on a single senior lender for debt extensions, material weaknesses in internal controls, and pending litigation, points to extreme financial instability and high risk for investors. While there are some positive project developments and tax credit opportunities, they are overshadowed by the immediate and existential financial threats.

Keywords

Renewable Natural Gas, Biofuels, Ethanol, Biodiesel, Sustainable Aviation Fuel (SAF), Renewable Diesel (RD), Carbon Capture and Sequestration (CCUS), Low Carbon Fuel Standard (LCFS), Renewable Fuel Standard (RFS), D3 RINs, Section 45Z Tax Credits, Dairy Digesters, Third Eye Capital, Going Concern, SEC 10-Q, Aemetis